Influenza IMPRINT Cohort: Defining the Impact of Initial Influenza Exposure on Immunity in Infants

Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY

The primary aim is to define the immune responses to the infant's initial influenza exposure (vaccine or infection) and how that affects the immune response to subsequent influenza exposures

Eligibility
Participation Requirements
Sex: All
Healthy Volunteers: t
View:

• Mother pregnant and ≥ 34 weeks gestation and ≥ 18 yrs. of age

• Plans to deliver at local hospital

• Lives within designated home zip codes:

• No plans to move outside study area within study timeframe

• Cell phone that can be used for text messaging

• Singleton live born infant, born ≥ 34 weeks gestational age (GA)

Locations
United States
Ohio
Cincinnati Children's Hospital Medical Center
RECRUITING
Cincinnati
Contact Information
Primary
Nancy Back, RN,MPH
Nancy.Back@cchmc.org
513-636-2479
Backup
Chelsea Rohlfs, MBA
Chelsea.Rohlfs@cchmc.org
513-636-0393
Time Frame
Start Date: 2019-10-17
Estimated Completion Date: 2028-12-31
Participants
Target number of participants: 1500
Treatments
Cincinnati IMPRINT birth cohort
mother-infant pairs enrolled at or after week 34 in pregnancy and followed over three flu seasons, up to four years of age.
Related Therapeutic Areas
Sponsors
Collaborators: National Institute of Allergy and Infectious Diseases (NIAID)
Leads: Children's Hospital Medical Center, Cincinnati

This content was sourced from clinicaltrials.gov

Similar Clinical Trials